203 results
Summary table of comparison of the difference between primary biliary cholangitis (PBC) and primary sclerosing cholangitis
Summary table of ... biliary cholangitis (PBC ... sclerosing cholangitis (PSC ... medical diagrams, tables ... #differential #hepatology
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Phytonadione), 4-factor PCC ... Andexxa), 4-factor PCC ... #pharmacology #hematology
Hepatocellular Carcinoma (HCC) Surveillance and Management

#HCC #Hepatocellular #Carcinoma #Surveillance #Management #Treatment #Hepatology
Hepatocellular Carcinoma (HCC ... Management #HCC ... Management #Treatment #Hepatology
Liver Mass Differential Diagnosis
Solid:
 • Benign: Hepatic Hemangioma, Focal nodular hyperplasia, Hepatocellular adenoma, Regenerative nodules
 •
• Malignant: HCC ... Cystadenocarcinoma, Primary SCC ... Differential #Diagnosis #hepatology
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Management #EM #IM #PCC ... Catecholamine #Comparison #Table
Cholestatic Liver Disease: Primary Biliary Cirrhosis vs Primary Sclerosing Cholangitis

#pathophysiology #pbc #psc #hepatology #comparison
pathophysiology #pbc ... #psc #hepatology
Hepatic Masses on CT - Differential Diagnosis by CT Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Adenoma, FNH, HCC ... Fibrolamellar HCC ... diagnosis #liver #hepatology
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
0.3-2.6%/year → HCC ... Cirrhotic NASH → HCC ... Progression #Timeline #hepatology
Sepsis Treatment Overview #Management #EM #IM #PCC #Sepsis #Overview #BMJ
Management #EM #IM #PCC
Hepatic Masses on MRI - Differential Diagnosis by MRI Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Adenoma, FNH, HCC ... Fibrolamellar HCC ... diagnosis #liver #hepatology